Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accelerated treatment.

H T Barkley

    Cancer
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Radiation therapy schedules have evolved, with early short treatments and later extended durations. Accelerated schedules show promise for rapidly growing tumors but require careful management to avoid normal tissue damage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Blalock-Taussig operation.

    The Journal of pediatrics·2010
    Same author

    Tuberculosis and cancer of the lung; errors in diagnosis.

    Medical record and annals·2010
    Same author

    Radiation therapy following resection of non-small cell bronchogenic carcinoma.

    International journal of radiation oncology, biology, physics·1991
    Same author

    Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer.

    Cancer·1989
    Same author

    Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection.

    International journal of radiation oncology, biology, physics·1988
    Same author

    Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancer.

    International journal of radiation oncology, biology, physics·1988
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Cancer Treatment

    Background:

    • Early 20th-century radiation oncology favored short treatment courses (≤2 weeks) based on the concept of brief tumor cell sensitivity.
    • Post-WWII, treatment durations extended to 5–8 weeks to mitigate acute normal tissue toxicity and escalate tumor doses.
    • Subsequent attempts at accelerated fractionation yielded poor outcomes, including severe normal tissue reactions and inadequate tumor control.

    Observation:

    • Clinical trials exploring large-fraction, shortened-overall-time radiation therapy resulted in significant normal tissue damage and failed to improve tumor control.
    • More recent acceleration strategies, such as hyperfractionation and continuous irradiation, often necessitated dose reductions or treatment interruptions due to unacceptable toxicity.
    • These historical attempts highlight the challenges in balancing tumor control with normal tissue sparing in radiation therapy.

    Related Experiment Videos

    Findings:

    • Accelerated radiation schedules have historically led to severe normal tissue reactions and compromised tumor control.
    • Current understanding suggests that accelerated fractionation is best reserved for specific clinical scenarios.
    • The optimal timing and fractionation of radiation therapy remain critical considerations in cancer treatment.

    Implications:

    • Accelerated radiation schedules should be cautiously applied, primarily for rapidly proliferating neoplasms or palliative care.
    • Further research is needed to optimize radiation fractionation and overall treatment time for various cancer types.
    • Understanding the radiobiology of tumor and normal tissues is crucial for developing safer and more effective radiation treatment strategies.